Abstract
The effects of exogenous histamine on nasal mucosal blood flow and the systemic activity of intranasally administered desmopressin, a vasopressin analogue, were studied in normal volunteers. Ten subjects received either saline or histamine (1, 20, 100, and 500 micrograms) by intranasal spray. Maximal nasal mucosal blood flow response, determined by laser doppler velocimetry, demonstrated a significant (P less than 0.05) linear relationship to histamine dose. Eight additional subjects received each of the following intranasal treatments: 20 micrograms histamine followed by 10 micrograms desmopressin; normal saline followed by 10 micrograms desmopressin; 20 micrograms histamine followed by vehicle; or normal saline and vehicle. Nasal blood flow was determined before and after each treatment. Desmopressin activity was assessed by measuring urine osmolality, flow rate, electrolyte, and creatinine concentration for 24 h after each treatment. The effect of histamine and desmopressin was greater than desmopressin alone, with respect to nasal blood flow response (103 +/- 24 vs. 4 +/- 17%, mean +/- SEM, P less than 0.02), initial urine osmolality (520 +/- 123 vs. 333 +/- 75 mosM, P less than 0.03), urine electrolyte (potassium, 45 +/- 11 vs. 28 +/- 7 meq/liter; sodium, 68 +/- 21 vs. 36 +/- 8 meq/liter, P less than 0.03) and creatinine concentrations (95 +/- 23 vs. 60 +/- 13 mg/dl, P less than 0.03), and the duration of decrease in urine flow rate compared with saline and vehicle. These results suggest that the systemic activity of intranasal desmopressin is enhanced by increasing local nasal blood flow and are consistent with increased transnasal absorption of the peptide.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andersson K. E., Arner B. Effects of DDAVP, a synthetic analogue of vasopressin, in patients with cranial diabetes insipidus. Acta Med Scand. 1972 Jul-Aug;192(1-2):21–27. doi: 10.1111/j.0954-6820.1972.tb04772.x. [DOI] [PubMed] [Google Scholar]
- Bende M., Andersson K. E., Johansson C. J., Sjögren C., Svensson G. Vascular effects of phenylpropanolamine on human nasal mucosa. Rhinology. 1985 Mar;23(1):43–48. [PubMed] [Google Scholar]
- Bende M. Blood flow with 133Xe in human nasal mucosa in relation to age, sex and body position. Acta Otolaryngol. 1983 Jul-Aug;96(1-2):175–179. doi: 10.3109/00016488309132889. [DOI] [PubMed] [Google Scholar]
- Bende M., Elner A., Ohlin P. The effect of provoked allergic reaction and histamine on nasal mucosal blood flow in humans. Acta Otolaryngol. 1984 Jan-Feb;97(1-2):99–104. doi: 10.3109/00016488409130969. [DOI] [PubMed] [Google Scholar]
- Bende M., Lindqvist N., Pipkorn U. Effect of a topical glucocorticoid, budesonide, on nasal mucosal blood flow as measured with 133Xe wash-out technique. Allergy. 1983 Oct;38(7):461–464. doi: 10.1111/j.1398-9995.1983.tb02354.x. [DOI] [PubMed] [Google Scholar]
- Bende M. Studies of blood flow in the human nasal mucosa. Eur J Respir Dis Suppl. 1983;128(Pt 2):400–402. [PubMed] [Google Scholar]
- Bisgaard H., Olsson P., Bende M. Leukotriene D4 increases nasal blood flow in humans. Prostaglandins. 1984 Apr;27(4):599–604. doi: 10.1016/0090-6980(84)90095-9. [DOI] [PubMed] [Google Scholar]
- Boucher R. C., Ranga V., Paré P. D., Inoue S., Moroz L. A., Hogg J. C. Effect of histamine and methacholine on guinea pig tracheal permeability to HRP. J Appl Physiol Respir Environ Exerc Physiol. 1978 Dec;45(6):939–948. doi: 10.1152/jappl.1978.45.6.939. [DOI] [PubMed] [Google Scholar]
- Braude S., Royston D., Coe C., Barnes P. J. Histamine increases lung permeability by an H2-receptor mechanism. Lancet. 1984 Aug 18;2(8399):372–374. doi: 10.1016/s0140-6736(84)90542-7. [DOI] [PubMed] [Google Scholar]
- Brooks C. D., Nelson A., Parzyck R., Maile M. H. Protective effect of hydroxyzine and phenylpropanolamine in the challenged allergic nose. Ann Allergy. 1981 Nov;47(5 Pt 1):316–319. [PubMed] [Google Scholar]
- Druce H. M., Bonner R. F., Patow C., Choo P., Summers R. J., Kaliner M. A. Response of nasal blood flow to neurohormones as measured by laser-Doppler velocimetry. J Appl Physiol Respir Environ Exerc Physiol. 1984 Oct;57(4):1276–1283. doi: 10.1152/jappl.1984.57.4.1276. [DOI] [PubMed] [Google Scholar]
- Elwany S., Toppozada M. The effects of topical dinoprostone on the nasal vasculature. A study of patients with allergic rhinitis. Arch Otolaryngol. 1983 Dec;109(12):815–817. doi: 10.1001/archotol.1983.00800260037009. [DOI] [PubMed] [Google Scholar]
- Hammer M., Vilhardt H. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin. J Pharmacol Exp Ther. 1985 Sep;234(3):754–760. [PubMed] [Google Scholar]
- Hiley C. R., Wilson H., Yates M. S. Identification of beta-adrenoceptors and histamine receptors in the cat nasal vasculature. Acta Otolaryngol. 1978 May-Jun;85(5-6):444–448. [PubMed] [Google Scholar]
- Hussain A. A., Hirai S., Bawarshi R. Nasal absorption of natural contraceptive steroids in rats-progesterone absorption. J Pharm Sci. 1981 Apr;70(4):466–467. doi: 10.1002/jps.2600700435. [DOI] [PubMed] [Google Scholar]
- Hussain A. A., Hirai S., Bawarshi R. Nasal absorption of propranolol in rats. J Pharm Sci. 1979 Sep;68(9):1196–1196. doi: 10.1002/jps.2600680942. [DOI] [PubMed] [Google Scholar]
- Inagaki M., Sakakura Y., Itoh H., Ukai K., Miyoshi Y. Macromolecular permeability of the tight junction of the human nasal mucosa. Rhinology. 1985 Sep;23(3):213–221. [PubMed] [Google Scholar]
- Lung M. A., Wang J. C. Nasal blood flow and airway resistance. Canine study. Ann Otol Rhinol Laryngol. 1985 Mar-Apr;94(2 Pt 1):198–201. doi: 10.1177/000348948509400221. [DOI] [PubMed] [Google Scholar]
- Malm L. Beta-adrenergic receptors in the vessels of the cat nasal mucosa. Acta Otolaryngol. 1974 Sep-Oct;78(3-4):242–246. doi: 10.3109/00016487409126350. [DOI] [PubMed] [Google Scholar]
- Nitzan M., Brama I., Mahler Y. Measurement of nasal mucosal blood flow by a thermal clearance method. IEEE Trans Biomed Eng. 1985 Dec;32(12):1063–1066. doi: 10.1109/TBME.1985.325516. [DOI] [PubMed] [Google Scholar]
- Olsson P., Bende M., Ohlin P. The laser Doppler flowmeter for measuring microcirculation in human nasal mucosa. Acta Otolaryngol. 1985 Jan-Feb;99(1-2):133–139. doi: 10.3109/00016488509119155. [DOI] [PubMed] [Google Scholar]
- Radó J. P., Marosi J., Fischer J. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus. Pharmacology. 1977;15(1):40–45. doi: 10.1159/000136661. [DOI] [PubMed] [Google Scholar]
- Radó J. P., Marosi J., Fischer J., Takó J., Kiss N. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man. Endokrinologie. 1975 Nov;66(2):184–195. [PubMed] [Google Scholar]
- Richardson D. W., Robinson A. G. Desmopressin. Ann Intern Med. 1985 Aug;103(2):228–239. doi: 10.7326/0003-4819-103-2-228. [DOI] [PubMed] [Google Scholar]
- Stern M. D., Lappe D. L., Bowen P. D., Chimosky J. E., Holloway G. A., Jr, Keiser H. R., Bowman R. L. Continuous measurement of tissue blood flow by laser-Doppler spectroscopy. Am J Physiol. 1977 Apr;232(4):H441–H448. doi: 10.1152/ajpheart.1977.232.4.H441. [DOI] [PubMed] [Google Scholar]
- Su K. S., Campanale K. M., Gries C. L. Nasal drug delivery system of a quaternary ammonium compound: clofilium tosylate. J Pharm Sci. 1984 Sep;73(9):1251–1254. doi: 10.1002/jps.2600730915. [DOI] [PubMed] [Google Scholar]
- Tanimoto H., Okuda M., Yagi T., Ohtsuka H. Measurement of the blood flow of the nasal mucosa by the hydrogen clearance method. Rhinology. 1983 Mar;21(1):59–65. [PubMed] [Google Scholar]
